 |
Dehydroepiandrosterone sulfate sodium |
|---|---|
| Trade Name | |
| Orphan Indication | To accelerate the re-epithelialization of donor sites in those hospitalized burn patients who must undergo autologous skin grafting |
| USA Market Approval | USA |
| USA Designation Date | 1997-01-28 00:00:00 |
| Sponsor | Pharmadigm, Inc.;2401 Foothill Drive;Salt Lake City, Utah, 84109 |
